STOCK TITAN

PTCT Rule 144 notice: proposed sale of 55,000 shares on 10/03/2025

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

PTC Therapeutics (PTCT) filed a Form 144 notice for a proposed sale of 55,000 shares of common stock. The filing lists an aggregate market value of $3,632,946.95 for the shares and an approximate sale date of 10/03/2025. The designated broker is Fidelity Brokerage Services LLC, and the shares are listed on NASDAQ.

The shares were acquired via an option grant dated 01/04/2016, from the issuer, with payment noted as cash on 10/03/2025. The filing also reports 79,438,094 shares outstanding. This notice reflects an intention to sell under Rule 144 and does not itself execute a transaction.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did PTCT disclose in this Form 144?

A proposed sale of 55,000 shares of common stock with an aggregate market value of $3,632,946.95.

When is the proposed sale date for PTCT shares?

The approximate sale date is 10/03/2025.

Which broker is listed for the PTCT Form 144 sale?

The filing names Fidelity Brokerage Services LLC as the broker.

On which exchange are the PTCT shares listed?

The shares are listed on NASDAQ.

How were the shares to be sold acquired?

They were acquired via an Option Granted - 01/04/2016 from the issuer, with cash payment dated 10/03/2025.

How many PTCT shares are outstanding according to the notice?

The filing reports 79,438,094 shares outstanding.

Does this Form 144 mean the sale has occurred?

No. It is a notice of proposed sale under Rule 144, not a completed transaction.
Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

6.10B
78.25M
2.47%
101.79%
8.36%
Biotechnology
Pharmaceutical Preparations
Link
United States
WARREN